A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales
Journal of Child and Adolescent Psychopharmacology · 2022-06 · 32 (5) · 278-287
DOI: 10.1089/cap.2021.0111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, online erschienen am 14.06.2022. Verfasst von Carl Y Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.
Themen: Depression
Abstract (Originalsprache)
Introduction
The Clinical Global Impressions-Improvement (CGI-I) scale is widely used in clinical research to assess symptoms and functioning in the context of treatment. The correlates of the CGI-I with efficacy scales for adolescent major depressive disorder are poorly understood. This study focused on benchmarking CGI-I scores with changes in the Children's Depression Rating Scale-Revised (CDRS-R) and the Quick Inventory of Depressive Symptomatology-Adolescent (17-item) Self-Report (QIDS-A17-SR).
Methods
We examined three datasets with the clinician-rated CDRS-R to ascertain equivalent percent changes in total scores and CGI-I ratings. Exploratory analyses examined corresponding percentage changes in the QIDS-A17-SR and the CGI-I ratings. The CGI-I was the reference scale for nonparametric equipercentile linking with the Equate package in R.
Results
CGI-I scores of 1 mapped to ≥78%–95% change in CDRS-R scores at 4–6 weeks across three datasets. CGI-I scores of 2 mapped to 56%–94% change in CDRS-R scores at 4–6 weeks across three studies. CGI-I scores of 3 mapped to 30%–68% changes in CDRS-R scores at 4–6 weeks across three studies. CGI-I scores of 4 mapped to a range of 29%–44% at 4–6 weeks across three studies. There was no significant difference ( p ≥ 0.6) between treatment groups in both the Treatment of Adolescents with Depression and Treatment of Resistant Depression in Adolescents studies, for each CGI-I score ( = 1, or = 2 or = 3, or ≥4), associated mapping of total depression severity score, or associated percent change from baseline for corresponding follow-up visits. There was no significant sex difference ( p > 0.2) in CGI-I linkages to CDRS-R total or percentage changes.
Conclusions
These findings establish clear relationships among CGI-I scores and the CDRS-R and the QIDS-A17-SR. These benchmarks have utility for clinical trial study design, inter-rater reliability training, and clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Economics, University of Cincinnati, Cincinnati, Ohio, USA.
- Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Children's Health, Children's Medical Center, Dallas, Texas, USA.
- Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, Florida, USA.
ORCID-Profile: Jeffrey R Strawn, Paul E Croarkin
Förderung
- NIMH NIH HHS
Zitieren
APA
Zhang, C. Y., Voort, J. L. V., Yuruk, D., Mills, J. A., Emslie, G. J., Kennard, B. D., Mayes, T., Trivedi, M., Bobo, W. V., Strawn, J. R., Athreya, A. P., & Croarkin, P. E. (2022). A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales. Journal of Child and Adolescent Psychopharmacology, 32(5), 278-287. https://doi.org/10.1089/cap.2021.0111
Vancouver
Zhang CY, Voort JLV, Yuruk D, Mills JA, Emslie GJ, Kennard BD, et al. A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales. Journal of Child and Adolescent Psychopharmacology. 2022;32(5):278-287. doi:10.1089/cap.2021.0111
BibTeX
@article{Zhang2022,
author = {Zhang, Carl Y and Voort, Jennifer L Vande and Yuruk, Deniz and Mills, Jeffrey A and Emslie, Graham J and Kennard, Betsy D and Mayes, Taryn and Trivedi, Madhukar and Bobo, William V and Strawn, Jeffrey R and Athreya, Arjun P and Croarkin, Paul E},
title = {A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2022},
volume = {32},
number = {5},
pages = {278--287},
doi = {10.1089/cap.2021.0111}
}
EUVIMED